Cumberland Pharmaceuticals (CPIX) Net Margin Growth (3y) (2013 - 2026)
Cumberland Pharmaceuticals (CPIX) Net Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 948.00 |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | -491.00 |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 83.00 |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | -94.00 |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | -990.00 |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | -604.00 |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 1,312.00 |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 116.48 Mn | 112.62 Mn | - | -257,579.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -71,095.00 |
| Mar 31, 2026 | -3,627.00 |
| Dec 31, 2024 | -2,427.00 |
| Sep 30, 2024 | -2,307.00 |
| Jun 30, 2024 | -1,670.00 |
| Mar 31, 2024 | -2,709.00 |
| Dec 31, 2023 | -7,588.00 |
| Sep 30, 2023 | -1,895.00 |
| Jun 30, 2023 | 22.00 |
| Mar 31, 2023 | -795.00 |
| Dec 31, 2021 | 5,064.00 |
| Sep 30, 2021 | 2,575.00 |
| Jun 30, 2021 | 1,284.00 |
| Mar 31, 2021 | 3,256.00 |
| Dec 31, 2020 | 1,555.00 |
| Sep 30, 2020 | 1,517.00 |
| Jun 30, 2020 | 6,743.00 |
| Mar 31, 2020 | 962.00 |
| Dec 31, 2019 | 3,424.00 |
| Sep 30, 2019 | 1,837.00 |